Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Erythromycin ethyl succinate 500mg tablets
0501050H0AAAEAE
|
Erythromycin ethylsuccinate | Erythromycin ethylsuccinate | Infections | 2,934 |
|
Lyrica 150mg capsules
0408010AEBBAEAE
|
Lyrica | Pregabalin | Central Nervous System | 2,932 |
|
Inhixa 40mg/0.4ml solution for injection pre-filled syringes
0208010D0BCABAB
|
Inhixa | Enoxaparin | Cardiovascular System | 2,931 |
|
KerraMaxCare dressing 20cm x 50cm rectangular
20031700174
|
KerraMaxCare dressing 20cm x 50cm rectangular | Wound Management & Other Dressings | Dressings | 2,929 |
|
SMA High Energy liquid
0913104A0BBAAAA
|
SMA ready to serve infant formula, high energy | Ready to serve infant formula, high energy (0913104) | Nutrition and Blood | 2,929 |
|
Xarelto 20mg tablets
0208020Y0BBACAC
|
Xarelto | Rivaroxaban | Cardiovascular System | 2,929 |
|
Stericlens sodium chloride 0.9% irrigation solution aerosol spray
21160000020
|
Stericlens sodium chloride 0.9% irrigation solution aerosol spray | Irrigation Solutions | Appliances | 2,922 |
|
Glycopyrronium bromide 1mg tablets
0102000L0AAACAC
|
Glycopyrronium bromide (Oral) | Glycopyrronium bromide | Gastro-Intestinal System | 2,920 |
|
E45 emollient bath oil
130201100BBAAAE
|
Proprietary compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | 2,919 |
|
Flupentixol 100mg/1ml solution for injection ampoules
0402020G0AAABAB
|
Flupentixol decanoate | Flupentixol decanoate | Central Nervous System | 2,915 |
|
Zuclopenthixol decanoate 500mg/1ml inj ampoules
0402020Z0AAABAB
|
Zuclopenthixol decanoate | Zuclopenthixol decanoate | Central Nervous System | 2,915 |
|
AgaMatrix Comfort Twist lancets 0.32mm/30gauge
21012600193
|
AgaMatrix Comfort Twist lancets 0.32mm/30gauge | Other Appliances | Appliances | 2,914 |
|
Hyoscine butylbromide 20mg tablets
0102000N0AAAUAU
|
Hyoscine butylbromide | Hyoscine butylbromide | Gastro-Intestinal System | 2,901 |
|
Hydrocortisone 0.1% cream
1304000V0AAAWAW
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 2,898 |
|
Alendronic acid 10mg tablets
0606020A0AAAAAA
|
Alendronic acid | Alendronic acid | Endocrine System | 2,892 |
|
SenSura Mio soft convex colostomy bag with filter, maxi soft cover 10-50mm
23351003851
|
SenSura Mio soft convex colostomy bag with filter, maxi soft cover 10-50mm | Colostomy Bags | Stoma Appliances | 2,891 |
|
Kapake 30mg/500mg tablets
0407010F0BHAAAH
|
Kapake | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 2,889 |
|
Xenidate XL 54mg tablets
0404000M0BIADAR
|
Xenidate | Methylphenidate hydrochloride | Central Nervous System | 2,888 |
|
Xylocaine 2% with Adrenaline 100microg/20ml inj vials
1502010J0BBA1A3
|
Xylocaine (Gel/Injection/Solution) | Lidocaine hydrochloride | Anaesthesia | 2,888 |
|
Aymes Actagain 2.4 Daily liquid (3 flavours)
0913011X0BBABAB
|
Aymes ready to serve 2.4 kcal/ml milkshake higher volume | Ready to serve 2.4 kcal/ml milkshake higher volume (0913011) | Nutrition and Blood | 2,886 |
|
CyanocoB12 1mg tablets
0901020D0BKABAF
|
CyanocoB12 | Cyanocobalamin | Nutrition and Blood | 2,886 |
|
HydroSil gripper catheter male 10Ch-18Ch
21020001170
|
HydroSil gripper catheter male 10Ch-18Ch | Catheters | Appliances | 2,886 |
|
Lipitor 80mg tablets
0212000B0BBADAD
|
Lipitor | Atorvastatin | Cardiovascular System | 2,883 |
|
LINC-Flo sterile leg bag with T tap 30cm inlet 500ml
22502655006
|
LINC-Flo sterile leg bag with T tap 30cm inlet 500ml | Leg Bags | Incontinence Appliances | 2,882 |
|
Ethinylestradiol 20microgram / Gestodene 75microgram tablets
0703010E0AAACAC
|
Combined ethinylestradiol 20mcg | Combined ethinylestradiol 20mcg | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,881 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.